Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P4501B1 variants in Escherichia coli

被引:18
作者
Shimada, T
Tsumura, F
Gillam, EMJ
Guengerich, FP
Inoue, K
机构
[1] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 5370025, Japan
[2] Univ Queensland, Dept Physiol & Pharmacol, St Lucia, Qld 4072, Australia
[3] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA
关键词
D O I
10.1006/prep.2000.1302
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Four human cytochrome P450 1B1 (CYP1B1) allelic variants were purified from membranes of Escherichia coli in which respective CYP1B1 cDNAs and human NADPH-P450 reductase cDNA have been introduced. Purified CYP1B1 variants were used to reconstitute 7-ethoxycoumarin O-deethylation activities with purified rabbit liver or recombinant (rat) NADPH-P450 reductase in the phospholipid vesicles and compared with those catalyzed by CYP1B1 enzymes in the membranes of E. coli in monocistronic (by adding the reductase) and bicistronic (without addition of extra reductase) systems. In the bicistronic system, the ratio of expression of NADPH-P450 reductase to CYP1B1 proteins was found to range from 0.2 to 0.5. Purified CYP1B1 enzymes (under optimal reconstitution conditions) catalyzed 7-ethoxycoumarin O-deethylation at rates one-third to one-fourth of those catalyzed by membranes of E. coli coexpressing CYP1B1 and the reductase proteins. Full catalytic activities in reconstituted systems were achieved with a twofold molar excess of NADPH-P450 reductase to CYP1B1; in membranes of E. coli with the monocistronic CYP1B1 construct, an eightfold molar excess of reductase to CYP1B1 was required. However, in membranes of bicistronic constructs, there was no additional stimulation of 7-ethoxycoumarin O-deethylation by extra NADPH-P450 reductase, despite the fact that the molar ratio of expression levels of reductase to CYP1B1 was <0.5. These results suggest that NADPH-P450 reductase produced in the bacterial membranes is more active in interacting with CYP1B1 proteins in the bicistronic system than the reductase added to artificial phospholipid vesicles or bacterial membranes, (C) 2000 Academic Press.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 46 条
[1]  
Bailey LR, 1998, CANCER RES, V58, P5038
[2]   Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia [J].
Bejjani, BA ;
Lewis, RA ;
Tomey, KF ;
Anderson, KL ;
Dueker, DK ;
Jabak, M ;
Astle, WF ;
Otterud, B ;
Leppert, M ;
Lupski, JR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :325-333
[3]  
Crespi C L, 1997, Adv Pharmacol, V43, P171, DOI 10.1016/S1054-3589(08)60205-7
[4]   Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: Substrate specificity with model substrates and promutagens [J].
Crespi, CL ;
Penman, BW ;
Steimel, TD ;
Smith, T ;
Yang, CS ;
Sutter, TR .
MUTAGENESIS, 1997, 12 (02) :83-89
[5]   Recombinant DNA technology as an investigative tool in drug metabolism research [J].
Friedberg, T ;
Wolf, CR .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) :187-213
[6]   CDNA-EXPRESSED HUMAN CYTOCHROME-P450S - A NEW AGE OF MOLECULAR TOXICOLOGY AND HUMAN RISK ASSESSMENT [J].
GONZALEZ, FJ ;
CRESPI, CL ;
GELBOIN, HV .
MUTATION RESEARCH, 1991, 247 (01) :113-127
[7]   ESTIMATION OF ISOZYMES OF MICROSOMAL CYTOCHROME-P-450 IN RATS, RABBITS, AND HUMANS USING IMMUNOCHEMICAL STAINING COUPLED WITH SODIUM DODECYL-SULFATE POLYACRYLAMIDE-GEL ELECTROPHORESIS [J].
GUENGERICH, FP ;
WANG, P ;
DAVIDSON, NK .
BIOCHEMISTRY, 1982, 21 (07) :1698-1706
[8]   New applications of bacterial systems to problems in toxicology [J].
Guengerich, FP ;
Gillam, EMJ ;
Shimada, T .
CRITICAL REVIEWS IN TOXICOLOGY, 1996, 26 (05) :551-583
[9]   EXPRESSION OF MODIFIED HUMAN CYTOCHROME-P450-1A1 IN ESCHERICHIA-COLI - EFFECTS OF 5' SUBSTITUTION, STABILIZATION, PURIFICATION, SPECTRAL CHARACTERIZATION, AND CATALYTIC PROPERTIES [J].
GUO, ZY ;
GILLAM, EMJ ;
OHMORI, S ;
TUKEY, RH ;
GUENGERICH, FP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 312 (02) :436-446
[10]   Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities [J].
Hanna, IH ;
Teiber, JF ;
Kokones, KL ;
Hollenberg, PF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 350 (02) :324-332